Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-311750
Filing Date
2020-12-07
Accepted
2020-12-07 16:10:22
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d83118d424b5.htm 424B5 371312
2 GRAPHIC g83118g61j23.jpg GRAPHIC 32072
3 GRAPHIC g83118g88n17.jpg GRAPHIC 112000
  Complete submission text file 0001193125-20-311750.txt   571106
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-234101 | Film No.: 201372835
SIC: 2836 Biological Products, (No Diagnostic Substances)